{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:42:00Z","timestamp":1789094520010,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T00:00:00Z","timestamp":1367539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11033-013-2512-8","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T17:49:13Z","timestamp":1367516953000},"page":"4109-4114","source":"Crossref","is-referenced-by-count":27,"title":["The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer"],"prefix":"10.1007","volume":"40","author":[{"given":"Slah","family":"Ouerhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bougatef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Ben Ammar","family":"Elgaaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Abbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Menif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,3]]},"reference":[{"key":"2512_CR1","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1101\/gad.11.19.2468","volume":"11","author":"L Johnson","year":"1997","unstructured":"Johnson L, Greenbaum D, Cichowski K et al (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11:2468\u20132481","journal-title":"Genes Dev"},{"issue":"1","key":"2512_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3(1):11\u201322","journal-title":"Nat Rev Cancer"},{"key":"2512_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30\u00a0years. Nat Rev Cancer 3:459\u2013465","journal-title":"Nat Rev Cancer"},{"key":"2512_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cub.2005.07.010","volume":"15","author":"N Mitin","year":"2005","unstructured":"Mitin N, Rossman K, Der C (2005) Signaling interplay in Ras super family function. Curr Biol 15:563\u2013574","journal-title":"Curr Biol"},{"issue":"10","key":"2512_CR5","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","volume":"72","author":"IA Prior","year":"2012","unstructured":"Prior IA, Lewis PD, Mattos C (2012) A comprehensive survey of Ras mutations in cancer. Cancer Res 72(10):2457\u20132467","journal-title":"Cancer Res"},{"key":"2512_CR6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jcp.20310","volume":"204","author":"D Calistri","year":"2005","unstructured":"Calistri D, Rengucci C, Seymour I et al (2005) Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. J Cell Physiol 204:484\u2013488","journal-title":"J Cell Physiol"},{"key":"2512_CR7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3748\/wjg.v16.i10.1177","volume":"16","author":"Z Saridaki","year":"2010","unstructured":"Saridaki Z, Georgoulias V, Souglakos J (2010) Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer. World J Gastroenterol 16:1177\u20131187","journal-title":"World J Gastroenterol"},{"key":"2512_CR8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q","volume":"89","author":"MP Zeegers","year":"2000","unstructured":"Zeegers MP, Tan FE, Dorant E, Van Den Brandt PA (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89:630\u2013639","journal-title":"Cancer"},{"key":"2512_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/03008880802291915","volume":"218","author":"C Cordon-Cardo","year":"2008","unstructured":"Cordon-Cardo C (2008) Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 218:154\u2013165","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"2512_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.urolonc.2009.04.019","volume":"28","author":"M Castillo-Martin","year":"2010","unstructured":"Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O et al (2010) Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 28:401\u2013408","journal-title":"Urol Oncol"},{"key":"2512_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/CBM-2011-0175","volume":"9","author":"B Czerniak","year":"2010","unstructured":"Czerniak B (2010) Molecular pathology and biomarkers of bladder cancer. Cancer Biomark 9:159\u2013176","journal-title":"Cancer Biomark"},{"key":"2512_CR12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1038\/sj.onc.1204315","volume":"20","author":"ZT Zhang","year":"2001","unstructured":"Zhang ZT, Pak J, Huang HY et al (2001) Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 20:1973\u20131980","journal-title":"Oncogene"},{"key":"2512_CR13","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/sj.onc.1208705","volume":"24","author":"AH Jebar","year":"2005","unstructured":"Jebar AH, Hurst CD, Tomlinson DC et al (2005) FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24:5218\u20135225","journal-title":"Oncogene"},{"key":"2512_CR14","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1371\/journal.pone.0013821","volume":"5","author":"LC Kompier","year":"2010","unstructured":"Kompier LC, Lurkin I, Van der Aa MN et al (2010) FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. PLoS One 5:13821","journal-title":"PLoS One"},{"key":"2512_CR15","first-page":"901","volume":"11\u201312","author":"LZ He","year":"1996","unstructured":"He LZ, Stephenson J, He GY, Mufti GJ (1996) RAS gene mutations in Chinese leukaemia patients and members of a family with high incidence of leukaemia. Leuk Res 11\u201312:901\u2013903","journal-title":"Leuk Res"},{"key":"2512_CR16","first-page":"357","volume-title":"Comparative Molecular Carcinogenesis","author":"CJ Conti","year":"1992","unstructured":"Conti CJ (1992) Mutations of genes of the ras family in humanand experimental tumors. In: Klein-Szanto AJP, Anderson MW, Barrett JC, Slaga TJ (eds) Comparative Molecular Carcinogenesis. Wiley-Liss, Inc., NewYork, pp 357\u2013378"},{"key":"2512_CR17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/path.995","volume":"195","author":"F Al-Mulla","year":"2001","unstructured":"Al-Mulla F, MacKenzie EM (2001) Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations. J Pathol 195:549\u2013556","journal-title":"J Pathol"},{"key":"2512_CR18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1182\/blood.V73.4.1028.1028","volume":"73","author":"SJ Collins","year":"1989","unstructured":"Collins SJ, Howard M, Andrews DF, Agura E, Radich J (1989) Rare occurrence of N-RAS point mutations in Philadelphia chromosome positive chronic myeloid leukaemia. Blood 73:1028","journal-title":"Blood"},{"issue":"14","key":"2512_CR19","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2010-10-311019","volume":"118","author":"AM Jankowska","year":"2011","unstructured":"Jankowska AM, Makishima H, Tiu RV et al (2011) Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood 118(14):3932\u20133941","journal-title":"Blood"},{"issue":"12","key":"2512_CR20","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/leu.2008.124","volume":"22","author":"A Agarwal","year":"2008","unstructured":"Agarwal A, Eide CA, Harlow A, Corbin AS et al (2008) An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia. Leukemia 22(12):2269\u20132272","journal-title":"Leukemia"},{"issue":"4","key":"2512_CR21","first-page":"237","volume":"5","author":"N Karimianpour","year":"2008","unstructured":"Karimianpour N, Mousavi-Shafaei P, Ziaee AA et al (2008) Mutations of RAS gene family in specimens of bladder cancer. Urol J 5(4):237\u2013242","journal-title":"Urol J"},{"issue":"3","key":"2512_CR22","first-page":"168","volume":"7","author":"MS Nanda","year":"2010","unstructured":"Nanda MS, Sameer AS, Syeed N et al (2010) Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population. Urol J 7(3):168\u2013173","journal-title":"Urol J"},{"key":"2512_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000282753","volume":"55","author":"T Uchida","year":"1995","unstructured":"Uchida T, Wada C, Ishida H et al (1995) Infrequent involvement of mutations on neurofibromatosis type 1, H-ras, K-ras and N-ras in urothelial tumors. Urol Int 55:63\u201367","journal-title":"Urol Int"},{"key":"2512_CR24","first-page":"2675","volume":"18","author":"G Olderoy","year":"1998","unstructured":"Olderoy G, Daehlin L, Ogreid D (1998) Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder. Anticancer Res 18:2675\u20132678","journal-title":"Anticancer Res"},{"key":"2512_CR25","first-page":"100","volume":"2","author":"MS Miller","year":"2011","unstructured":"Miller MS, Miller LD (2011) RAS mutations and oncogenesis: not all RAS mutations are created equally. Front Genet 2:100","journal-title":"Front Genet"},{"key":"2512_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1383-5742(00)00047-8","volume":"463","author":"KY Seo","year":"2000","unstructured":"Seo KY, Jelinsky SA, Loechler EL (2000) Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat Res 463:215\u2013246","journal-title":"Mutat Res"},{"key":"2512_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2362.1990.tb01848.x","volume":"20","author":"M Barbacid","year":"1990","unstructured":"Barbacid M (1990) Ras oncogenes: their role in neoplasia. Eur J Clin Invest 20:225\u2013235","journal-title":"Eur J Clin Invest"},{"key":"2512_CR28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1289\/ehp.9193125","volume":"93","author":"G Capella","year":"1991","unstructured":"Capella G, Cronauer-Mitra S, Pienado MA, Perucho M (1991) Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 93:125\u2013131","journal-title":"Environ Health Perspect"},{"key":"2512_CR29","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1001\/jama.2010.1535","volume":"304","author":"W Roock De","year":"2010","unstructured":"De Roock W, Jonker DJ, Di Nicolantonio F et al (2010) Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. JAMA 304:1812\u20131820","journal-title":"JAMA"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2512-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2512-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2512-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T05:48:10Z","timestamp":1595742490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2512-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,3]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2512-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,3]]}}}